Aratana Therapeutics Reports Second Quarter 2013 Financial Results
8/13/2013 6:12:21 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
KANSAS CITY, Kan. and BOSTON, Aug. 12, 2013 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX) today announced its financial results for the second quarter of 2013, product development updates and the continued build-out of its pipeline.
For the quarter ended June 30, 2013, the Company reported a net loss of $4.2 million, or $(4.62) per share, compared with a net loss of $3.1 million, or $(10.21) per share for the quarter ended June 30, 2012.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by